A qualitative immunoassay to detect the presence of immunoglobulin M (IgM) antibodies directed against the core antigen of hepatitis B virus (HBV) in blood serum. This test is considered a distinctive marker for acute hepatitis B infection, as these antibodies appear in the first phase of infection and remain for several months.